Table 1 Patient and treatment characteristics
Characteristic | Number | Percent |
|---|---|---|
Total | 375 | 100 |
Median age (yr) | 71 (51–92) | |
≤ 70 yr | 185 | 49.3 |
> 70 yr | 190 | 50.7 |
T stage | ||
T1-T2 | 261 | 69.6 |
T3-T4 | 103 | 27.5 |
Unknown | 11 | 2.9 |
NCCN risk group | ||
Intermediate | 143 | 38.1 |
High | 232 | 61.9 |
Gleason Score | ||
< 8 | 241 | 64.3 |
8–10 | 133 | 35.5 |
Unknown | 1 | 0.3 |
PSA on presentation | ||
≤ 20 ng/ml | 253 | 67.5 |
> 20 ng/ml | 118 | 31.5 |
Unknown | 4 | 1 |
Median ADT duration (months) | 10 (3–36) | – |
Median Radiation Dose (Gy) | 72 (70–78) | – |
< 72 | 44 | 11.7 |
≥ 72 | 327 | 87.2 |
Unknown | 4 | 1.1 |